News

Microbia, a producer of sustainable specialty ingredients and biomaterials, has achieved an important milestone in creating its line of naturally derived carotenoids for the food ingredient and nutritional

Hi-Tech Pharmacal (Hi-Tech) has received clearance from the FDA to market Tropazone lotion, a prescription dermatological product which is expected to be promoted by Hi-Tech’s branded marketing subsidiary,

Vivus has reported positive results from a phase 2 study evaluating the safety and efficacy of Qnexa, an investigational drug, for the treatment of obstructive sleep apnea (OSA).

Reata Pharmaceuticals (Reata) and Kyowa Hakko Kirin have entered into a licensing agreement that provides the latter with the exclusive rights to develop and commercialise Reata’s lead compound,

GeneGo has launched easy access to many Sigma Aldrich life science and chemistry products from their ‘Drug Details’ pages in three products: MetaCore 6.0, MetaDrug and Eureka. This

MediPEEK-IM advantages are biocompatibility, mechanical strength/toughness, superior hydrolysis and chemical resistance with dimensional stability, sterilizable and radio translucent with natural color. Modern Plastics is a distributor for Westlake

Gilead Sciences (Gilead) has reported that Phase II clinical trial of its investigational integrase inhibitor-based, once-daily, fixed-dose ‘Quad’ regimen of elvitegravir, GS 9350 and Truvada (emtricitabine and tenofovir

Seaside Therapeutics has entered into a collaborative research agreement with Vanderbilt University Medical Center to discover and develop small molecules targeting neurologic receptors implicated in disorders of brain

Keryx Biopharmaceuticals has reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a phase 3 clinical program for Zerenex (ferric citrate).